Fixed and Low-Dose Combinations of Blood Pressure-Lowering Agents: For the Many or the Few?

Massimo Leggio, Augusto Fusco, Claudia Loreti, Giorgio Limongelli, Maria Grazia Bendini, Andrea Mazza, Antonio Frizziero, Daniele Coraci, Luca Padua

Research output: Contribution to journalArticle

Abstract

Despite the widespread availability of several effective classes of drugs, systemic arterial hypertension remains poorly controlled in the majority of patients worldwide. In this article, we discuss the different modalities and effects of combination therapy and possible future research questions. Treatment with a single antihypertensive agent can effectively reduce blood pressure in only a limited number of patients, while most require therapy with two or more agents to achieve target levels. As initial therapy, American and European guidelines suggest a combination of two antihypertensive drugs and the use of a third antihypertensive drug when hypertension is still uncontrolled. Initial combination therapy is recommended in high-risk patients for an immediate blood pressure response, improved tolerability and possibly increased patient adherence. In addition to the potential benefits of combining different drug classes with synergistic pharmacological and physiological actions, this approach is useful for increasing the patient compliance with treatment, in particular if provided at fixed doses in a single pill. The minimisation of side effects is critical for the long-term treatment of a largely asymptomatic condition such as systemic hypertension. Low-dose combinations of different drugs from classes with complementary actions may provide the best ratio of lower side effects and improved tolerability with a significant blood pressure reduction, particularly in high-risk patients. This approach could be aided by a multidisciplinary lifestyle intervention on risk factors.

Original languageEnglish
JournalDrugs
DOIs
Publication statusAccepted/In press - Jan 1 2019

Fingerprint

Blood Pressure
Antihypertensive Agents
Patient Compliance
Hypertension
Therapeutics
Asymptomatic Diseases
Drug Combinations
Pharmaceutical Preparations
Life Style
Pharmacology
Guidelines

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Fixed and Low-Dose Combinations of Blood Pressure-Lowering Agents : For the Many or the Few? / Leggio, Massimo; Fusco, Augusto; Loreti, Claudia; Limongelli, Giorgio; Bendini, Maria Grazia; Mazza, Andrea; Frizziero, Antonio; Coraci, Daniele; Padua, Luca.

In: Drugs, 01.01.2019.

Research output: Contribution to journalArticle

Leggio, Massimo ; Fusco, Augusto ; Loreti, Claudia ; Limongelli, Giorgio ; Bendini, Maria Grazia ; Mazza, Andrea ; Frizziero, Antonio ; Coraci, Daniele ; Padua, Luca. / Fixed and Low-Dose Combinations of Blood Pressure-Lowering Agents : For the Many or the Few?. In: Drugs. 2019.
@article{7ac51283f2b74705ae92016afb865a33,
title = "Fixed and Low-Dose Combinations of Blood Pressure-Lowering Agents: For the Many or the Few?",
abstract = "Despite the widespread availability of several effective classes of drugs, systemic arterial hypertension remains poorly controlled in the majority of patients worldwide. In this article, we discuss the different modalities and effects of combination therapy and possible future research questions. Treatment with a single antihypertensive agent can effectively reduce blood pressure in only a limited number of patients, while most require therapy with two or more agents to achieve target levels. As initial therapy, American and European guidelines suggest a combination of two antihypertensive drugs and the use of a third antihypertensive drug when hypertension is still uncontrolled. Initial combination therapy is recommended in high-risk patients for an immediate blood pressure response, improved tolerability and possibly increased patient adherence. In addition to the potential benefits of combining different drug classes with synergistic pharmacological and physiological actions, this approach is useful for increasing the patient compliance with treatment, in particular if provided at fixed doses in a single pill. The minimisation of side effects is critical for the long-term treatment of a largely asymptomatic condition such as systemic hypertension. Low-dose combinations of different drugs from classes with complementary actions may provide the best ratio of lower side effects and improved tolerability with a significant blood pressure reduction, particularly in high-risk patients. This approach could be aided by a multidisciplinary lifestyle intervention on risk factors.",
author = "Massimo Leggio and Augusto Fusco and Claudia Loreti and Giorgio Limongelli and Bendini, {Maria Grazia} and Andrea Mazza and Antonio Frizziero and Daniele Coraci and Luca Padua",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s40265-019-01209-7",
language = "English",
journal = "Drugs",
issn = "0012-6667",
publisher = "Adis International Ltd",

}

TY - JOUR

T1 - Fixed and Low-Dose Combinations of Blood Pressure-Lowering Agents

T2 - For the Many or the Few?

AU - Leggio, Massimo

AU - Fusco, Augusto

AU - Loreti, Claudia

AU - Limongelli, Giorgio

AU - Bendini, Maria Grazia

AU - Mazza, Andrea

AU - Frizziero, Antonio

AU - Coraci, Daniele

AU - Padua, Luca

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Despite the widespread availability of several effective classes of drugs, systemic arterial hypertension remains poorly controlled in the majority of patients worldwide. In this article, we discuss the different modalities and effects of combination therapy and possible future research questions. Treatment with a single antihypertensive agent can effectively reduce blood pressure in only a limited number of patients, while most require therapy with two or more agents to achieve target levels. As initial therapy, American and European guidelines suggest a combination of two antihypertensive drugs and the use of a third antihypertensive drug when hypertension is still uncontrolled. Initial combination therapy is recommended in high-risk patients for an immediate blood pressure response, improved tolerability and possibly increased patient adherence. In addition to the potential benefits of combining different drug classes with synergistic pharmacological and physiological actions, this approach is useful for increasing the patient compliance with treatment, in particular if provided at fixed doses in a single pill. The minimisation of side effects is critical for the long-term treatment of a largely asymptomatic condition such as systemic hypertension. Low-dose combinations of different drugs from classes with complementary actions may provide the best ratio of lower side effects and improved tolerability with a significant blood pressure reduction, particularly in high-risk patients. This approach could be aided by a multidisciplinary lifestyle intervention on risk factors.

AB - Despite the widespread availability of several effective classes of drugs, systemic arterial hypertension remains poorly controlled in the majority of patients worldwide. In this article, we discuss the different modalities and effects of combination therapy and possible future research questions. Treatment with a single antihypertensive agent can effectively reduce blood pressure in only a limited number of patients, while most require therapy with two or more agents to achieve target levels. As initial therapy, American and European guidelines suggest a combination of two antihypertensive drugs and the use of a third antihypertensive drug when hypertension is still uncontrolled. Initial combination therapy is recommended in high-risk patients for an immediate blood pressure response, improved tolerability and possibly increased patient adherence. In addition to the potential benefits of combining different drug classes with synergistic pharmacological and physiological actions, this approach is useful for increasing the patient compliance with treatment, in particular if provided at fixed doses in a single pill. The minimisation of side effects is critical for the long-term treatment of a largely asymptomatic condition such as systemic hypertension. Low-dose combinations of different drugs from classes with complementary actions may provide the best ratio of lower side effects and improved tolerability with a significant blood pressure reduction, particularly in high-risk patients. This approach could be aided by a multidisciplinary lifestyle intervention on risk factors.

UR - http://www.scopus.com/inward/record.url?scp=85074487898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074487898&partnerID=8YFLogxK

U2 - 10.1007/s40265-019-01209-7

DO - 10.1007/s40265-019-01209-7

M3 - Article

C2 - 31602564

AN - SCOPUS:85074487898

JO - Drugs

JF - Drugs

SN - 0012-6667

ER -